In addition, TAMs modulate tumor metastasis by regulating the EMT process through STAT/miR-506-3p/FoxQ1 signaling and TAT/miR-506-3p/FoxQ1 pathway and promote extracellular matrix degradation via secreting matrix metalloproteinases and C-C motif chemokine ligand 18 (CCL18) (56–60). This evidence concerns the gene CCL18 and neoplasm.